Cargando…

Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series

Detalles Bibliográficos
Autores principales: Abasszade, Joshua Haron, La, Paul Bao Duy, Shelmerdine, Emily, Nalpantidis, Anastasios, Curtin, Natasha, Grigoriadis, George, Fedele, Pasquale Luke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Pathologists of Australasia. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355740/
https://www.ncbi.nlm.nih.gov/pubmed/35989103
http://dx.doi.org/10.1016/j.pathol.2022.07.002
_version_ 1784763363548463104
author Abasszade, Joshua Haron
La, Paul Bao Duy
Shelmerdine, Emily
Nalpantidis, Anastasios
Curtin, Natasha
Grigoriadis, George
Fedele, Pasquale Luke
author_facet Abasszade, Joshua Haron
La, Paul Bao Duy
Shelmerdine, Emily
Nalpantidis, Anastasios
Curtin, Natasha
Grigoriadis, George
Fedele, Pasquale Luke
author_sort Abasszade, Joshua Haron
collection PubMed
description
format Online
Article
Text
id pubmed-9355740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Royal College of Pathologists of Australasia. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-93557402022-08-07 Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series Abasszade, Joshua Haron La, Paul Bao Duy Shelmerdine, Emily Nalpantidis, Anastasios Curtin, Natasha Grigoriadis, George Fedele, Pasquale Luke Pathology Correspondence Royal College of Pathologists of Australasia. Published by Elsevier B.V. 2022-10 2022-08-06 /pmc/articles/PMC9355740/ /pubmed/35989103 http://dx.doi.org/10.1016/j.pathol.2022.07.002 Text en © 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Abasszade, Joshua Haron
La, Paul Bao Duy
Shelmerdine, Emily
Nalpantidis, Anastasios
Curtin, Natasha
Grigoriadis, George
Fedele, Pasquale Luke
Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series
title Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series
title_full Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series
title_fullStr Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series
title_full_unstemmed Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series
title_short Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series
title_sort severe autoimmune haemolytic anaemia following sars-cov-2 vaccination in patients with treatment naïve b-cell neoplasms: a case series
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355740/
https://www.ncbi.nlm.nih.gov/pubmed/35989103
http://dx.doi.org/10.1016/j.pathol.2022.07.002
work_keys_str_mv AT abasszadejoshuaharon severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries
AT lapaulbaoduy severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries
AT shelmerdineemily severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries
AT nalpantidisanastasios severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries
AT curtinnatasha severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries
AT grigoriadisgeorge severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries
AT fedelepasqualeluke severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries